Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients...

Ogkologos - 2 Δεκεμβρίου, 2024

Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in...

Ogkologos - 29 Νοεμβρίου, 2024

Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative...

Ogkologos - 28 Νοεμβρίου, 2024

ESMO Asia Congress 2024, Singapore, 6-8 December

Ogkologos - 27 Νοεμβρίου, 2024

EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib

Ogkologos - 27 Νοεμβρίου, 2024

FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid...

Ogkologos - 26 Νοεμβρίου, 2024

Adding Pembrolizumab to Chemotherapy Results in Improved PFS and OS in...

Ogkologos - 25 Νοεμβρίου, 2024

Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...

Ogkologos - 22 Νοεμβρίου, 2024

Trial Results Support SBRT as a Standard Option for Some Prostate...

Ogkologos - 21 Νοεμβρίου, 2024

Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage...

Ogkologos - 21 Νοεμβρίου, 2024

1...636465...440 Σελίδα 64 από 440

MOST POPULAR

Geriatric Assessment Intervention Reduces Patient-Reported Symptomatic Toxicities in Older Patients with...

17 Νοεμβρίου, 2022

Targeting the Accomplice: A Potential Treatment Approach for Rhabdomyosarcoma

3 Αυγούστου, 2022

Coping with COVID: New Stimulus Funds and Unemployment Benefit Update

5 Ιανουαρίου, 2021

‘Being open will help bring awareness’: Meet the fashion vlogger who...

16 Νοεμβρίου, 2022

Φόρτωση περισσοτέρων

Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients...

Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in...

Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative...

ESMO Asia Congress 2024, Singapore, 6-8 December

EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib

FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid...

Adding Pembrolizumab to Chemotherapy Results in Improved PFS and OS in...

Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...

Trial Results Support SBRT as a Standard Option for Some Prostate...

Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage...

MOST POPULAR

Geriatric Assessment Intervention Reduces Patient-Reported Symptomatic Toxicities in Older Patients with...

Targeting the Accomplice: A Potential Treatment Approach for Rhabdomyosarcoma

Coping with COVID: New Stimulus Funds and Unemployment Benefit Update

‘Being open will help bring awareness’: Meet the fashion vlogger who...

HOT NEWS

Latest episode of our podcast for cancer researchers

Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated...

FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer

Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ